Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The SRY-box transcription factor 9 (SOX9) mRNA 3' untranslated region (3'UTR) is a critical regulatory segment of the SOX9 transcript that governs protein expression through post-transcriptional mechanisms (NCBI Gene ID: 6662). SOX9 is a master transcription factor essential for chondrogenesis and male gonad development, but its overexpression is a hallmark of various cancers, including colorectal, breast, and lung carcinomas (UniProt: P48436). The 3'UTR serves as a scaffold for microRNAs (miRNAs) and RNA-binding proteins that modulate the stability and translation of the mRNA transcript. In many pathological states, the downregulation of tumor-suppressive miRNAs like miR-145 or miR-101 leads to the stabilization of SOX9 mRNA, driving epithelial-mesenchymal transition (EMT) and tumor progression (PubMed: 28651317). Therapeutic strategies targeting this region involve the use of miRNA mimics or antisense oligonucleotides (ASOs) to restore regulatory control and reduce SOX9 protein levels (PubMed: 30210156). This makes the SOX9 mRNA 3'UTR a significant focal point for the development of precision RNA-based therapeutics in oncology and regenerative medicine.
Binding of complementary RNA sequences or antisense oligonucleotides to the 3'UTR to induce mRNA degradation or translational repression via the RNA-induced silencing complex (RISC) (PubMed: 24510005).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SRY-box transcription factor 9 mRNA 3' untranslated region (SOX9 mRNA 3'UTR).